Additional European Equity News

AstraZeneca (AZN LN) - Q4 (USD): Core EPS 2.12 (exp. 2.14), Revenue 15.5bln (exp. 15.46bln), guides initial FY26 revenue up by mid-to-high single digit and core EPS up by double-digit percentage. (AstraZeneca) 

Barclays (BARC LN) - Q4 (GBP) Revenue 7.08bln (prev. 6.96bln Y/Y), PBT 1.86bln (exp. 1.76bln), NII 3.73bln (exp. 3.76bln); announces share buyback of GBP 1bln with plan to return at least £10bn of capital to shareholders between 2024 and 2026, through dividends and share buybacks, with a continued preference for buybacks. (Barclays)

Bellway (BWY LN) - 6 months trading update (2026): Growth in total housing completions to 4,702 homes (2025 – 4.6k) at an average selling price of around GBP 322k (2025 – GBP 310k). The forward order book at 31 January 2026 comprised 4.4k homes (2025 – 4.7k), with a value of GBP 1.24bln (2025 – £1.31bln). The GBP 150mln share buyback launched on 14 October 2025 is progressing well, with 1.76mln shares purchased at a cost of around GBP 48mln during the period. (Bellway) 

BP (BP/ LN) - Q4 2025 (USD): Adj. EPS 0.10 (exp. 0.099), Adj. Net 1.5bln (exp. 1.53bln), Board has decided to suspend share buybacks; Net Debt 22.18bln (exp. 23.04bln); Dividend per share 8.32c (exp. 8.29c); Operating Cash Flow 7.6bln (exp. 7.4bln); Reduces capital expenditure for 2026 to lower end of guided range. (BP) 

BT (BT/A LN) - Co. announces new leaders for Openreach and BT International (BT)

Coca-Cola HBC (CCH LN) - FY 2025 (GBP): Net sales revenue 11.6bln (prev. 10.75bln Y/Y), Operating profit 1.31bln (prev. 1.19bln Y/Y), EPS 2.59 (prev. 2.25 Y/Y). (Coca Cola HBC)

GSK (GSK LN) - Co.’s RSV vaccine, Arexy, accepted for regulatory review in China for adults aged 60 years and older. (GSK) 

Pennon Group (PNN LN) - Co. confirms news CEO start data (Pennon Group)

STMicroelectronics (STM FP) - Co. introduces the first automotive microcontroller with AI for edge intelligence. (STM FP)

Thule (THULE SS) - Q4 (SEK): Sales 1.84bln (exp. 1.78bln). FY: Net Sales 10.42bln (prev. 9.54bln Y/Y), EPS 10.33 (prev. 10.59 Y/Y). Proposes a dividend of SEK 8.30/shr (prev. SEK 8.30 Y/Y). (Thule) 

BASF (BAS GY) reiterates with Buy at Goldman Sachs 

Croda International (CRDA LN) reiterates with Sell at Goldman Sachs 

Novonesis (NSISB DC) reiterates with Buy at Goldman Sachs

10 Feb 2026 - 07:01- ForexEU Research- Source: Newsquawk